InvestorQ : What explains the sharp fall in net profits of Jubilant Life Sciences in the Jun-20 quarter?
Rashi Mehra made post

What explains the sharp fall in net profits of Jubilant Life Sciences in the Jun-20 quarter?

Answer
user profile image
Archita Jajjoo answered.
4 weeks ago


Jubilant Life Sciences reported a 52.42% decline in net profit to Rs.88 crore for the Jun-20 quarter. However, the fall in revenues was a lot lower, falling by just about 13% to Rs.1893 crore due to the impact of COVID-19.

Drug Discovery and Development revenues increased by 25% to Rs.60 crore, albeit on a small base. This was the only segment of the company that showed positive growth with LSI and the pharmaceuticals segment showing negative growth in the Jun-20 quarter.